FedBizOpps banner

Login to begin searching the FBO/CBD
Home Page
CBD/FBO Online
CBD/FBO Email
About Us
Contact Us
Privacy
Categories
No. Notes
Archives
Search
Help
Login
Register

Popular Searches

Popular Categories

HLA Typing

General Information

Document Type:SRCSGT
Posted Date:May 25, 2019
Category: Research and Development
Set Aside:N/A

Contracting Office Address

3900 NCTR Road, HFT-320 Bldg 50 | Rm 421 Jefferson AR 72079

Description

MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION The U.S. Food and Drug Administration (FDA), is conducting market research to support the Center for Biologics Evaluation and Research (CBER), to require HLA Typing to support hemophilia genetic project at CBER. The FDA is seeking small business sources to determine the availability and capability of small business manufacturers or small businesses capable of supplying, a U.S. made product of a small business manufacturer or producer for the items described herein. Other than small business concerns are also encouraged to submit capability statements. The following information is provided to assist the FDA in conducting Market Research to identify potential contractors for this effort. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (25-MAY-2019); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.

Original Point of Contact

POC ROOSEVELT D. WALKER, CONTRACT SPECIALIST, Phone 8705437405

Place of Performance

Address:
FDA / CBER 10903 New Hampshire Ave, WO52/72 Room 4120 Silver Springs, MD
20993, US
Link: Link To Document
Bookmark This Notice
Print View